Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-005087
Filing Date
2013-04-29
Accepted
2013-04-29 17:13:39
Documents
6
Period of Report
2013-06-12
Effectiveness Date
2013-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214707zdef14a.htm DEF 14A 777761
2 G259977.JPG g259977.jpg GRAPHIC 8621
3 G242831.JPG g242831.jpg GRAPHIC 13374
4 G147406.JPG g147406.jpg GRAPHIC 12946
5 G18782BCI001.GIF g18782bci001.gif GRAPHIC 74772
6 G18782BCI002.GIF g18782bci002.gif GRAPHIC 46194
  Complete submission text file 0001047469-13-005087.txt   994432
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

EIN.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27628 | Film No.: 13792802
SIC: 2834 Pharmaceutical Preparations